Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Mary Gerrard"'
Publikováno v:
AANA journal. 89(4)
Gertrude Gerrard is a relatively unknown but important early nurse anesthetist in the United Sates in the early part of the 20th century. She was in the first class to graduate from the Peter Bent Brigham Hospital (PBBH) School of Nursing in Boston,
Autor:
Mary, Gerrard, Ian M, Waxman, Richard, Sposto, Anne, Auperin, Sherrie L, Perkins, Stanton, Goldman, Lauren, Harrison, Ross, Pinkerton, Keith, McCarthy, Martine, Raphael, Catherine, Patte, Mitchell S, Cairo
Publikováno v:
Blood. 121:278-285
Mediastinal large B-cell lymphoma (MLBL) represents 2% of mature B-cell non-Hodgkin lymphoma in patients ≤ 18 years of age. We analyzed data from childhood and adolescent patients with stage III MLBL (n = 42) and non-MLBL DLBCL (n = 69) treated wit
Autor:
Heidi Traunecker, Veronica Neefjes, Elise Ruark, Barry Pizer, Charles A. Stiller, Mary Gerrard, Rosa Maria Munoz-Xicola, Paul E. Grundy, Jeffrey S. Dome, Ingrid Slade, Anthony Renwick, Elizabeth R Perdeaux, Gill Levitt, Juliet Hale, Mabrook Madi, Bruce Morland, Nazneen Rahman, David Pernet, Sandra Hanks, Milind Ronghe, Kathy Pritchard-Jones, Michael Stevens, Arlene Naranjo, J.A. Kohler, Sheila Seal, Susan Picton, Anna Zachariou, Margaret Warren-Perry, Martin Hewitt, Clare Turnbull, James Nicholson, Sheila Lane
Publikováno v:
Nature genetics
Wilms tumor is the most common renal malignancy of childhood. To identify common variants that confer susceptibility to Wilms tumor, we conducted a genome-wide association study in 757 individuals with Wilms tumor (cases) and 1,879 controls. We evalu
Autor:
Mary Gerrard, A. Auperin, Keith McCarthy, Ross Pinkerton, Richard Sposto, Mitchell S. Cairo, Catherine Patte, Sherrie L. Perkins, Martine Raphael, Lauren Harrison, Stanton Goldman
Publikováno v:
Journal of Clinical Oncology. 30:387-393
Purpose Adolescents (age 15 to 21 years) compared with younger children with mature B-cell non-Hodgkin's lymphoma (NHL) have been historically considered to have an inferior prognosis. We therefore analyzed the impact of age and other diagnostic fact
Autor:
Gaëlle Pierron, Andrew D.J. Pearson, B. De Bernardi, Ruth Ladenstein, Nathalie Auger, Gian Paolo Tonini, Mary Gerrard, Combaret, Bárbara Marques, K Wheeler, Klaus Beiske, A F de Lacerda, Jérôme Couturier, Olivier Delattre, Jean Bénard, Deborah A. Tweddle, Gudrun Schleiermacher, Bénédicte Brichard, Agnès Ribeiro, Hervé Rubie, Rosa Noguera, I.M. Ambros, Castel, Mosseri, Katia Mazzocco, Nick Bown, Adela Cañete, R. Defferrari, Caroline Munzer, Peter F. Ambros, Jean Michon, Isabelle Janoueix-Lerosey, A. Di Cataldo, Eva Villamón, N. Van Roy
Publikováno v:
British Journal of Cancer
BRITISH JOURNAL OF CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
BRITISH JOURNAL OF CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
BACKGROUND: In neuroblastoma (NB), the presence of segmental chromosome alterations (SCAs) is associated with a higher risk of relapse. METHODS: In order to analyse the role of SCAs in infants with localised unresectable/disseminated NB without MYCN
Autor:
K. McCarthy, Mitchell S. Cairo, Anne Auperin, E. Launay, Mary Gerrard, Sherrie L. Perkins, Richard Sposto, Warren G. Sanger, John Swansbury, Nyla A. Heerema, Martine Raphael, Alain Bernheim, Polly Talley, Hélène Poirel, Catherine Patte
Publikováno v:
Leukemia
Clinical studies showed that advanced stage, high LDH, poor response to reduction therapy and combined bone marrow and central nervous system disease are significantly associated with a decreased event-free survival (EFS) in pediatric mature B-cell n
Autor:
Keith McCarthy, Mark A. Lones, Catherine Patte, Rodney R. Miles, Andrew Wotherspoon, Mitchell S. Cairo, Mary Gerrard, Marie José Terrier-Lacombe, Richard Sposto, Sherrie L. Perkins, Martine Raphael, Anne Auperin, Virginia Davenport
Publikováno v:
Pediatric Blood & Cancer. 51:369-374
Background Diffuse large B-cell lymphoma (DLBCL) makes up 10–20% of pediatric non-Hodgkin lymphoma, and these patients have a significantly better prognosis than adults with DLBCL. The difference in prognosis may be related to clinical, phenotypic,
Autor:
C. Ross Pinkerton, Claire Weston, Jean Michon, Richard Sposto, Martine Raphael, Anne Auperin, Mary Gerrard, Catherine Patte, Sherrie L. Perkins, Keith McCarthy, Mitchell S. Cairo
Publikováno v:
Blood. 109:2736-2743
The prognosis for higher risk childhood B-cell non-Hodgkin lymphoma has improved over the past 20 years but the optimal intensity of treatment has yet to be determined. Children 21 years old or younger with newly diagnosed B-cell non-Hodgkin lymphoma
Autor:
Ross Pinkerton, Jean Michon, Mary Gerrard, Sherrie L. Perkins, Richard Sposto, Martine Raphael, Claire Weston, Anne Auperin, Mitchell S. Cairo, Catherine Patte, Keith McCarthy
Publikováno v:
Blood. 109:2773-2780
A previous study (LMB89) of the French Society of Pediatric Oncology for childhood mature B-cell lymphoma (B-NHL) demonstrated a 92% 3-year event-free survival (EFS) for intermediate-risk group B defined as “non-resected” stage I/II and CNS-negat
Autor:
Mary Gerrard
Publikováno v:
Current Paediatrics. 13:207-212
Around 100 new cases of non-Hodgkin's lymphoma are diagnosed each year in the UK, accounting for 7% of childhood cancer. Immunophenotype and stage are used to determine treatment, current treatment resulting in more than 70% long-term survival. The e